OmniAb (OABI) Revenue & Revenue Breakdown
OmniAb Revenue Highlights
Latest Revenue (Y)
$34.16M
Latest Revenue (Q)
$7.61M
Main Segment (Y)
Service
OmniAb Revenue by Period
OmniAb Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $34.16M | -42.17% |
| 2022-12-31 | $59.08M | 70.02% |
| 2021-12-31 | $34.75M | 49.34% |
| 2020-12-31 | $23.27M | 27.02% |
| 2019-12-31 | $18.32M | - |
OmniAb generated $34.16M in revenue during NA 2023, up -42.17% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
OmniAb Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $7.61M | 100.32% |
| 2024-03-31 | $3.80M | -21.17% |
| 2023-12-31 | $4.82M | -11.96% |
| 2023-09-30 | $5.48M | -21.15% |
| 2023-06-30 | $6.95M | -58.95% |
| 2023-03-31 | $16.92M | -52.13% |
| 2022-12-31 | $35.34M | 411.51% |
| 2022-09-30 | $6.91M | -4.01% |
| 2022-06-30 | $7.20M | -25.19% |
| 2022-03-31 | $9.62M | -55.36% |
| 2021-12-31 | $21.56M | 243.43% |
| 2021-09-30 | $6.28M | 12.39% |
| 2021-06-30 | $5.58M | -15.32% |
| 2021-03-31 | $6.60M | -50.51% |
| 2020-12-31 | $13.33M | 167.25% |
| 2020-09-30 | $4.99M | - |
OmniAb generated $7.61M in revenue during Q2 2024, up 100.32% compared to the previous quarter, and up 45.00% compared to the same period a year ago.
OmniAb Revenue Breakdown
OmniAb Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 |
|---|---|
| Royalty | $1.28M |
| Service | $12.18M |
OmniAb's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (90.46%), and Royalty (9.54%).
Quarterly Revenue by Product
| Product/Service | Dec 23 | Sep 23 |
|---|---|---|
| Royalty | $834.00K | $451.00K |
| Service | $9.16M | $3.02M |
OmniAb's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Service (91.66%), and Royalty (8.34%).
OmniAb Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LEGN | Legend Biotech | $285.14M | $93.99M |
| OABI | OmniAb | $34.16M | $7.61M |
| IDYA | IDEAYA Biosciences | $23.39M | - |
| ITOS | iTeos Therapeutics | $12.60M | - |
| IKNA | Ikena Oncology | $9.16M | - |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| KROS | Keros Therapeutics | $151.00K | $83.00K |
| CGEM | Cullinan Oncology | - | - |
| BCAB | BioAtla | - | - |
| NGM | NGM Biopharmaceuticals | - | $165.00K |
| VRNA | Verona Pharma | - | - |
| TALS | Tourmaline Bio | - | - |
| OLMA | Olema Pharmaceuticals | - | - |
| ACET | Adicet Bio | - | - |
| ERAS | Erasca | - | - |
| PASG | Passage Bio | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| VOR | Vor Biopharma | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| EWTX | Edgewise Therapeutics | - | - |
OABI Revenue FAQ
What is OmniAb’s yearly revenue?
OmniAb's yearly revenue for 2023 was $34.16M, representing a decrease of -42.17% compared to 2022. The company's yearly revenue for 2022 was $59.08M, representing an increase of 70.02% compared to 2021. OABI's yearly revenue for 2021 was $34.75M, representing an increase of 49.34% compared to 2020.
What is OmniAb’s quarterly revenue?
OmniAb's quarterly revenue for Q2 2024 was $7.61M, a 100.32% increase from the previous quarter (Q1 2024), and a 9.62% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.8M, a -21.17% decrease from the previous quarter (Q4 2023), and a -77.53% decrease year-over-year (Q1 2023). OABI's quarterly revenue for Q4 2023 was $4.82M, a -11.96% decrease from the previous quarter (Q3 2023), and a -86.36% decrease year-over-year (Q4 2022).
What is OmniAb’s revenue growth rate?
OmniAb's revenue growth rate for the last 3 years (2021-2023) was -1.68%, and for the last 5 years (2019-2023) was 86.51%.
What are OmniAb’s revenue streams?
OmniAb's revenue streams in c 23 are Royalty, and Service. Royalty generated $1.28M in revenue, accounting 9.54% of the company's total revenue Service generated $12.18M in revenue, accounting 90.46% of the company's total revenue
What is OmniAb’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of OmniAb was Service. This segment made a revenue of $12.18M, representing 90.46% of the company's total revenue.